Literature DB >> 21620697

Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs.

Longqin Hu1, Xinghua Wu, Jiye Han, Lin Chen, Simon O Vass, Patrick Browne, Belinda S Hall, Christopher Bot, Vithurshaa Gobalakrishnapillai, Peter F Searle, Richard J Knox, Shane R Wilkinson.   

Abstract

A series of nitrobenzyl phosphoramide mustards and their analogs was designed and synthesized to explore their structure-activity relationships as substrates of nitroreductases from Escherichia coli and trypanosomes and as potential antiproliferative and antiparasitic agents. The position of the nitro group on the phenyl ring was important with the 4-nitrobenzyl phosphoramide mustard (1) offering the best combination of enzyme activity and antiproliferative effect against both mammalian and trypanosomatid cells. A preference was observed for halogen substitutions ortho to benzyl phosphoramide mustard but distinct differences were found in their SAR of substituted 4-nitrobenzyl phosphoramide mustards in E. coli nitroreductase-expressing cells and in trypanosomatids expressing endogenous nitroreductases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620697     DOI: 10.1016/j.bmcl.2011.05.009

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.

Authors:  Belinda S Hall; Emma Louise Meredith; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

2.  Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Marcel Kaiser; Eric Chatelain; Jean-Robert Ioset
Journal:  Bioorg Med Chem       Date:  2013-08-20       Impact factor: 3.641

3.  Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Eric Chatelain; Marcel Kaiser; Shane R Wilkinson; Caroline McKenzie; Jean-Robert Ioset
Journal:  J Med Chem       Date:  2012-05-23       Impact factor: 7.446

4.  Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.

Authors:  Maria V Papadopoulou; Bernadette Bourdin Trunz; William D Bloomer; Caroline McKenzie; Shane R Wilkinson; Chaiya Prasittichai; Reto Brun; Marcel Kaiser; Els Torreele
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

5.  Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Rachel Ashworth; Shane R Wilkinson; Marcel Kaiser; Grasiella Andriani; Ana Rodriguez
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

6.  An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.

Authors:  Andrew A Voak; Vithurshaa Gobalakrishnapillai; Karin Seifert; Edina Balczo; Longqin Hu; Belinda S Hall; Shane R Wilkinson
Journal:  J Biol Chem       Date:  2013-08-14       Impact factor: 5.157

7.  C60 Fullerene Effects on Diphenyl-N-(trichloroacetyl)-amidophosphate Interaction with DNA In Silico and Its Cytotoxic Activity Against Human Leukemic Cell Line In Vitro.

Authors:  A Grebinyk; S Prylutska; I Grynyuk; B Kolp; V Hurmach; T Sliva; V Amirkhanov; V Trush; O Matyshevska; M Slobodyanik; Yu Prylutskyy; M Frohme; U Ritter
Journal:  Nanoscale Res Lett       Date:  2018-03-09       Impact factor: 4.703

Review 8.  An Update on African Trypanocide Pharmaceutics and Resistance.

Authors:  Keneth Iceland Kasozi; Ewan Thomas MacLeod; Ibrahim Ntulume; Susan Christina Welburn
Journal:  Front Vet Sci       Date:  2022-03-07

9.  A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro.

Authors:  Linna Zhou; Gavin Stewart; Emeline Rideau; Nicholas J Westwood; Terry K Smith
Journal:  J Med Chem       Date:  2013-01-15       Impact factor: 7.446

10.  The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug.

Authors:  Ping Song; Xin Yao; Ting Zhong; Shuang Zhang; Yang Guo; Wei Ren; Dan Huang; Xiao-Chuan Duan; Yi-Fan Yin; Shu-Shi Zhang; Xuan Zhang
Journal:  Oncotarget       Date:  2016-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.